$XNCR
Xencor Inc

2023 Q3 Form 10-Q Financial Statement

#000132673223000026 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $59.20M $45.52M
YoY Change 116.85% 50.74%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $12.50M $11.46M
YoY Change 1.02% 3.33%
% of Gross Profit
Research & Development $64.94M $60.06M
YoY Change 21.9% 27.56%
% of Gross Profit
Depreciation & Amortization $3.200M $2.885M
YoY Change 42.98% 29.72%
% of Gross Profit
Operating Expenses $77.43M $71.52M
YoY Change 17.95% 22.94%
Operating Profit -$18.27M -$26.00M
YoY Change -52.36% -7.15%
Interest Expense -$6.000M $4.052M
YoY Change -189.85% -169.53%
% of Operating Profit
Other Income/Expense, Net -$6.001M -$9.000K
YoY Change -189.88% -99.85%
Pretax Income -$24.27M -$21.95M
YoY Change -23.37% -35.38%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$24.27M -$21.95M
YoY Change -25.92% -35.38%
Net Earnings / Revenue -40.99% -48.23%
Basic Earnings Per Share -$0.40 -$0.37
Diluted Earnings Per Share -$0.40 -$0.37
COMMON SHARES
Basic Shares Outstanding 60.61M shares 60.39M shares
Diluted Shares Outstanding 60.62M shares 59.81M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $494.5M $551.4M
YoY Change -17.62% 7.71%
Cash & Equivalents $52.73M $34.71M
Short-Term Investments $441.8M $516.7M
Other Short-Term Assets $21.60M $22.17M
YoY Change -5.62% 12.35%
Inventory
Prepaid Expenses
Receivables $55.00M $20.02M
Other Receivables $0.00 $0.00
Total Short-Term Assets $571.2M $593.6M
YoY Change -14.49% 1.3%
LONG-TERM ASSETS
Property, Plant & Equipment $68.04M $101.0M
YoY Change 33.3% 160.05%
Goodwill
YoY Change
Intangibles $18.74M $18.71M
YoY Change 3.59% 4.26%
Long-Term Investments $84.60M $64.21M
YoY Change 16.14% -62.57%
Other Assets $660.0K $598.0K
YoY Change 7.67% -2.45%
Total Long-Term Assets $207.3M $184.6M
YoY Change 23.9% -30.46%
TOTAL ASSETS
Total Short-Term Assets $571.2M $593.6M
Total Long-Term Assets $207.3M $184.6M
Total Assets $778.4M $778.1M
YoY Change -6.8% -8.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.97M $14.10M
YoY Change 2.39% -10.48%
Accrued Expenses $24.47M $22.67M
YoY Change 26.87% 38.66%
Deferred Revenue $9.200M $7.900M
YoY Change -73.85% -77.62%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.04M $44.63M
YoY Change -41.09% -40.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $56.40M $54.62M
YoY Change 150.23% 60.9%
Total Long-Term Liabilities $56.40M $54.62M
YoY Change 150.23% 60.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.04M $44.63M
Total Long-Term Liabilities $56.40M $54.62M
Total Liabilities $109.4M $99.25M
YoY Change -2.8% -8.94%
SHAREHOLDERS EQUITY
Retained Earnings -$445.3M -$421.0M
YoY Change 36.48% 43.45%
Common Stock $607.0K $607.0K
YoY Change 1.51% 1.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $669.0M $678.9M
YoY Change
Total Liabilities & Shareholders Equity $778.4M $778.1M
YoY Change -6.8% -8.6%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$24.27M -$21.95M
YoY Change -25.92% -35.38%
Depreciation, Depletion And Amortization $3.200M $2.885M
YoY Change 42.98% 29.72%
Cash From Operating Activities -$27.30M -$38.20M
YoY Change 2237.33% -186.29%
INVESTING ACTIVITIES
Capital Expenditures $3.400M $4.936M
YoY Change -122.87% -133.7%
Acquisitions
YoY Change
Other Investing Activities $48.70M $3.531M
YoY Change 170.71% -105.79%
Cash From Investing Activities $45.40M -$1.405M
YoY Change 1352.8% -98.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 400.0K 1.921M
YoY Change -68.92% -23.56%
NET CHANGE
Cash From Operating Activities -27.30M -38.20M
Cash From Investing Activities 45.40M -1.405M
Cash From Financing Activities 400.0K 1.921M
Net Change In Cash 18.50M -37.68M
YoY Change 470.28% 30.59%
FREE CASH FLOW
Cash From Operating Activities -$27.30M -$38.20M
Capital Expenditures $3.400M $4.936M
Free Cash Flow -$30.70M -$43.14M
YoY Change -324.14% -173.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
dei Entity Central Index Key
EntityCentralIndexKey
0001326732
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Address City Or Town
EntityAddressCityOrTown
Pasadena
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91107
dei City Area Code
CityAreaCode
626
dei Local Phone Number
LocalPhoneNumber
305-5900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
XNCR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60613236 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34710000 usd
CY2023Q2 us-gaap Debt Securities Current
DebtSecuritiesCurrent
476667000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
39995000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20019000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22171000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
593562000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67997000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18708000 usd
CY2023Q2 us-gaap Debt Securities Noncurrent
DebtSecuritiesNoncurrent
0 usd
CY2022Q4 us-gaap Debt Securities Noncurrent
DebtSecuritiesNoncurrent
3826000 usd
CY2023Q2 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
64210000 usd
CY2022Q4 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
54383000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33046000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34419000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
598000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
613000 usd
CY2023Q2 us-gaap Assets
Assets
778121000 usd
CY2022Q4 us-gaap Assets
Assets
846266000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
14097000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10088000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18440000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18728000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4228000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4708000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7865000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30320000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44630000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63844000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54615000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54926000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
99245000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
118770000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60600060 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60600060 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59997713 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
607000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
601000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1101131000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1072132000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1860000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6952000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-421002000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-338285000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
678876000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
727496000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
778121000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
846266000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45523000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30175000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64485000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60060000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47084000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
124439000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11460000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11091000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25408000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
71520000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
58175000 usd
us-gaap Operating Expenses
OperatingExpenses
149847000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25997000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-85362000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3764000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
717000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
6656000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-147000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1401000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
288000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-6545000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2610000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4043000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-21954000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-33975000 usd
us-gaap Net Income Loss
NetIncomeLoss
-82717000 usd
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1765000 usd
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1823000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
5093000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-7435000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20189000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35798000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-77624000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17815000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59807558 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59807558 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59567139 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59567139 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59922784 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59922784 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59487924 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59487924 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
727496000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
924000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57436000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12599000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
683583000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
677000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1242000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20189000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13563000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
678876000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
733504000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
731000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17983000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10805000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
763023000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1316000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1197000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35798000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12603000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
742341000 usd
us-gaap Profit Loss
ProfitLoss
-82717000 usd
us-gaap Profit Loss
ProfitLoss
-10380000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5130000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4402000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4345000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-968000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
26162000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23408000 usd
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
594000 usd
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
1047000 usd
xncr Equity Received In Connection With Sale Of Financial Assets
EquityReceivedInConnectionWithSaleOfFinancialAssets
10000000 usd
xncr Equity Received In Connection With Sale Of Financial Assets
EquityReceivedInConnectionWithSaleOfFinancialAssets
0 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-2610000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-9974000 usd
xncr Equity Securities Impairment
EquitySecuritiesImpairment
0 usd
xncr Equity Securities Impairment
EquitySecuritiesImpairment
138000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1379000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-125000 usd
xncr Increase Decrease In Accounts And Other Receivables And Contract With Customer Assets
IncreaseDecreaseInAccountsAndOtherReceivablesAndContractWithCustomerAssets
-8978000 usd
xncr Increase Decrease In Accounts And Other Receivables And Contract With Customer Assets
IncreaseDecreaseInAccountsAndOtherReceivablesAndContractWithCustomerAssets
-12100000 usd
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-420000 usd
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
448000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1127000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4183000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4009000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3197000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14636000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1746000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-288000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3095000 usd
xncr Increase Decrease In Lease Liabilities And Right Of Use Assets
IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets
582000 usd
xncr Increase Decrease In Lease Liabilities And Right Of Use Assets
IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets
7911000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-22455000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1995000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68814000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
50084000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
276715000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
206148000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1490000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14443000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
339580000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
76390000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46739000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-147398000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1601000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2047000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1242000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1197000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2843000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3244000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19232000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-94070000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53942000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
143480000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34710000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49410000 usd
us-gaap Interest Paid Net
InterestPaidNet
14000 usd
us-gaap Interest Paid Net
InterestPaidNet
9000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
5093000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-7435000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of interim financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, other comprehensive gain (loss) and the related disclosures. On an ongoing basis, management evaluates its estimates, including estimates related to its accrued clinical trial and manufacturing development expenses, stock-based compensation expense, evaluation of intangible assets, investments, leases and other assets for evidence of impairment, fair value measurements, and contingencies. Significant estimates in these interim financial statements include estimates made for royalty revenue, accrued research and development expenses, stock-based compensation expenses, intangible assets, incremental borrowing rate for right-of-use asset and lease liability, estimated standalone selling price of performance obligations, estimated time for completing delivery of performance obligations under certain arrangements, the likelihood of recognizing variable consideration, the carrying value of equity instruments without a readily determinable fair value, and recoverability of deferred tax assets.</span></div>
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0 usd
xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0 usd
CY2023Q2 xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0 usd
CY2022Q2 xncr Marketable Securities Impairment Losses And Recoveries
MarketableSecuritiesImpairmentLossesAndRecoveries
0 usd
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1800000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
5100000 usd
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1800000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-7400000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2022Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
100000 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
100000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21954000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33975000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-82717000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10380000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59807558 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59807558 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59567139 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59567139 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59922784 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59922784 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59487924 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59487924 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2023Q2 xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
499938000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
22000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1871000 usd
CY2023Q2 us-gaap Investments
Investments
498089000 usd
CY2023Q2 us-gaap Investments
Investments
498089000 usd
CY2022Q4 xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
578424000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6945000 usd
CY2022Q4 us-gaap Investments
Investments
571482000 usd
CY2022Q4 us-gaap Investments
Investments
571482000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
478516000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
476667000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
343159000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1871000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
457591000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6940000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
3826000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
5000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
300000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2600000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-6500000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-10000000 usd
CY2023Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
288000 usd
CY2022Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-6545000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-2610000 usd
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-9974000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
13563000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
12603000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
26162000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23408000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
13563000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
12603000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
26162000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23408000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3021000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6072000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7392000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8589000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8829000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9076000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
66435000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
109414000 usd
CY2023Q2 xncr Lessee Operating Lease Liability Tenant Allowance
LesseeOperatingLeaseLiabilityTenantAllowance
5459000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
45112000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
58843000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4228000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54615000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
58843000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2020000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1574000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
4200000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3136000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
219000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
33000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
453000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
132000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
2239000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
1607000 usd
us-gaap Lease Cost
LeaseCost
4653000 usd
us-gaap Lease Cost
LeaseCost
3268000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
721000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
665000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1445000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1349000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y8M12D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.089
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
xncr Number Of Technology License Agreements
NumberOfTechnologyLicenseAgreements
2 agreement
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45500000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30200000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64500000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115700000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
45500000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30200000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64500000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115700000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7900000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35300000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001326732-23-000026-index-headers.html Edgar Link pending
0001326732-23-000026-index.html Edgar Link pending
0001326732-23-000026.txt Edgar Link pending
0001326732-23-000026-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xncr-20230630.htm Edgar Link pending
xncr-20230630.xsd Edgar Link pending
xncr-20230630xexx101.htm Edgar Link pending
xncr-20230630xexx311.htm Edgar Link pending
xncr-20230630xexx312.htm Edgar Link pending
xncr-20230630xexx321.htm Edgar Link pending
xncr-20230630_def.xml Edgar Link unprocessable
xncr-20230630_pre.xml Edgar Link unprocessable
xncr-20230630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
xncr-20230630_cal.xml Edgar Link unprocessable
xncr-20230630_lab.xml Edgar Link unprocessable